Clinical Trials Browser

Phase 1 × Non-hematologic Malignancy × sapanisertib × Clear all

NCT02412722 2020-02-28

A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies

Phase 1 Completed

61 enrolled 33 charts

Non-hematologic Malignancy